Salcit Technologies
Salcit Technologies is an India-based respiratory healthcare company that built Swaasa, a patented AI platform analyzing cough sounds via smartphone to screen for COPD, asthma, pneumonia, and tuberculosis, serving healthcare providers, public health programs, corporates, and digital platforms globally.
- Company typePrivate
- Founded2017
- HeadquartersHyderabad, India
- Headcount—
- GTM typeB2B
- OfferingSoftware
What Salcit Technologies does
Salcit Technologies Private Limited is a Hyderabad, India-based respiratory healthcare company founded in 2017 that develops Swaasa®, an AI/ML platform analyzing cough sounds captured via smartphone microphones to screen for respiratory diseases including COPD, asthma, bronchitis, pneumonia, and tuberculosis. The platform's core is a patented ML model — an ensemble of advanced machine learning algorithms fusing cough audio analysis with patient vitals (temperature, oxygen saturation, medical history, symptoms) to generate instant respiratory health insights, effectively replicating spirometry functionality without specialized equipment or trained personnel. Swaasa is certified as a CDSCO Class B Software as a Medical Device, HIPAA-ready, ISO 13485 and ISO 27001 aligned, and is built on AWS cloud infrastructure with NVIDIA ecosystem support.
The company monetizes through a SaaS subscription model for enterprise customers and API-based licensing for digital platforms seeking to embed cough screening into existing user journeys. Its go-to-market targets four customer segments — healthcare providers and public health programs as primary segments, with corporates (employee wellness) and digital platforms as secondary segments — using direct enterprise field sales, self-serve website access, OEM/API distribution, and government public health program deployment. Reference customers include AIIMS and Apollo Hospitals, and the company operates offices in India, Canada, the US, and UAE. Operational status is active, with clinical validation studies presented at the 2024 European Respiratory Society Congress and recognition through multiple industry awards, though revenue, funding, and headcount (~30 staff) data remain limited.
Salcit Technologies firmographics
Firmographics- Name
- Salcit Technologies
- Legal name
- Salcit Technologies Private Limited
- Website
- https://salcit.in
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Short description
- Salcit Technologies is an India-based respiratory healthcare company that built Swaasa, a patented AI platform analyzing cough sounds via smartphone to screen for COPD, asthma, pneumonia, and tuberculosis, serving healthcare providers, public health programs, corporates, and digital platforms globally.
- Ownership category
- akta.pro rank
Salcit Technologies industry classification
Industry- Product category
- AI-powered Respiratory Diagnostics Software
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Respiratory & Sleep RPM (COPD, asthma, sleep apnea) (HLALAFAB)
- akta.pro secondary industries
- SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG), Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software (HLACANAD)
Keywords
Where Salcit Technologies is headquartered
LocationHeadquarters
- HQ city
- Hyderabad
- HQ country
- India
- HQ region
- Asia
Offices4 records
Markets served
Salcit Technologies business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales
Revenue model
- SaaS Platform Subscription: Subscription-based access to Swaasa platform for respiratory screening, monitoring, and assessment. Sold to healthcare providers, enterprises, and public health programs.
- API Access/Integration: API-based integration services for digital platforms extending user journeys through Swaasa capabilities.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels4 records
Salcit Technologies product offering
Product offeringCore offering
Salcit Technologies develops Swaasa®, an AI-powered respiratory health assessment platform that analyzes cough sounds captured through a smartphone microphone to evaluate lung health. The platform uses proprietary machine learning models running on AWS cloud infrastructure to provide accessible, non-invasive respiratory screening without requiring specialized equipment or trained personnel. It is a CDSCO-approved Class B Software as a Medical Device (SaMD), marketed to healthcare providers, enterprises, public health programs, and digital health platforms globally.
Product overview
Salcit Technologies offers a single unified product platform called Swaasa®, an AI-powered respiratory healthcare solution. The platform uses artificial intelligence and machine learning to analyze cough sounds and assess lung health. Swaasa® is designed for healthcare providers, corporates, digital platforms, and public health programs, enabling patient screening and remote patient monitoring through a guided workflow that captures cough samples, processes them through AI models, and delivers structured risk insights and reports.
Differentiator
Problem solved
Functional benefit
Brands
- Swaasa®: AI-powered respiratory health assessment platform that uses cough sound analysis to screen for respiratory diseases including COPD, asthma, bronchitis, pneumonia, and tuberculosis.
Products and services
- Swaasa®
Quantifiable outcome
- Clinical validation studies presented at the 2024 European Respiratory Society Congress demonstrating efficacy for respiratory disease screening
Companies that use Salcit Technologies
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles4 records
Salcit Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature4 records
Salcit Technologies partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- NVIDIAcoreProud member of NVIDIA ecosystem, leveraging GPU technology for AI/ML model training and inference for cough sound analysis.
- Government of Andhra PradeshcoreSelected as finalist in MedTech Innovation Challenge 2026 with government hospitals pilot testing; active government partnership for respiratory health programs.
- Digital India CorporationminorPartner organization under Ministry of Electronics and Information Technology supporting digital initiatives.
- KIIT TBI (KIIT Technology Business Incubator)minorTechnology business incubator partnership for startup support and development.
- IKPminorIncubator and accelerator partnership supporting healthcare innovation.
- ARIminorPartnership for respiratory health research and development.
- Amazon Web Services (AWS)coreCloud infrastructure provider powering Swaasa platform for reliable, secure, and scalable deployment. Enables high availability, real-time data processing, and seamless performance for large-scale screening programs.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
Salcit Technologies competitors and assessment
Company assessmentDirect peers
- Hyfe: Hyfe develops AI-based cough detection and monitoring using smartphones, with respiratory-health and clinical-research applications. Its acoustic cough monitoring directly overlaps Swaasa's smartphone cough analysis and respiratory-screening proposition.
- Sonovum: Sonovum develops AI-based lung-sound analysis and respiratory-monitoring products. Its focus on acoustic lung assessment and early respiratory detection is closely comparable to Swaasa's cough-signal platform.
- ResApp Health: ResApp Health developed smartphone applications that use cough sounds to screen for respiratory disease, making its acoustic diagnostic approach highly comparable to Swaasa. Pfizer acquired ResApp in 2022, so it is a relevant historical and technology benchmark rather than a current standalone competitor.
- NuvoAir: NuvoAir provides virtual respiratory care, spirometry, and remote monitoring for asthma, COPD, and other chronic respiratory conditions. It serves similar providers and patients and competes for respiratory screening and monitoring workflows, although its core offering is broader care management.
- Aluna: Aluna offers a digital respiratory-health platform with spirometry, symptom tracking, and provider-facing data. It is comparable in respiratory screening, remote monitoring, and target customers, even though its input modality is broader than cough sounds.
Emerging players
- Propeller Health: Propeller Health offers connected-inhaler sensors and digital respiratory management for asthma and COPD. It targets the same chronic respiratory populations and care workflows, even though its sensor model differs from Swaasa's acoustic analysis.
- Aevice Health: Aevice Health develops AI-enabled wearable respiratory monitoring for chronic respiratory conditions. Its focus on continuous respiratory monitoring and provider or patient use overlaps Swaasa's remote-respiratory-monitoring proposition.
- Spire Health: Spire Health provides wearable remote-patient monitoring focused on respiratory rate, sleep, and related physiology. It competes for provider-driven respiratory remote-monitoring and care-management budgets, although it is not cough-specific.
Broad incumbents
- ResMed: ResMed is a global respiratory-device and digital-health company with connected-care capabilities for sleep and breathing conditions. Its scale, provider relationships, and digital-respiratory portfolio make it a broad incumbent benchmark for Salcit's enterprise and remote-monitoring strategy.
- Vitalograph: Vitalograph is an established respiratory-diagnostics and pulmonary-function-testing company spanning spirometry and related monitoring tools. It provides an incumbent benchmark for the clinical workflows and equipment that Swaasa aims to augment or replace.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Salcit Technologies social profiles
Digital presenceSalcit Technologies compliance and trust
Trust signalCompliance4 records
Salcit Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Salcit Technologies leadership team
Management profileNumber of profiles
Profiles7 records
Salcit Technologies funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Salcit Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Salcit Technologies
What does Salcit Technologies do?
Salcit Technologies develops Swaasa®, an AI-powered respiratory health assessment platform that analyzes cough sounds captured through a smartphone microphone to evaluate lung health. The platform uses proprietary machine learning models running on AWS cloud infrastructure to provide accessible, non-invasive respiratory screening without requiring specialized equipment or trained personnel. It is a CDSCO-approved Class B Software as a Medical Device (SaMD), marketed to healthcare providers, enterprises, public health programs, and digital health platforms globally.
Is Salcit Technologies a public or private company?
Salcit Technologies is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Salcit Technologies founded?
Salcit Technologies was founded in 2017.
Where is Salcit Technologies based?
Salcit Technologies is headquartered in Hyderabad, India, in the Asia region.
How does Salcit Technologies make money?
Two revenue lines are on record. SaaS Platform Subscription is the primary driver. The others are API Access/Integration.
Who are Salcit Technologies's main competitors?
Direct peers on record are Hyfe, Sonovum, ResApp Health, NuvoAir and Aluna. Emerging players are Propeller Health, Aevice Health and Spire Health. Broad incumbents are ResMed and Vitalograph.
Does Salcit Technologies have an API?
Yes. Swaasa offers API-based integration capabilities for digital platforms to extend user journeys. The platform is designed to support integration with enterprise systems and public health programs, enabling screening data to be incorporated into existing workflows.
What industry is Salcit Technologies in?
Salcit Technologies's product category is AI-powered Respiratory Diagnostics Software. Its primary akta.pro industry code is HLALAFAB, Respiratory & Sleep RPM (COPD, asthma, sleep apnea), with a secondary code of HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML). Its NAICS code is 5417 and its SIC code is 3841.